Abstract
Inclination for hyperinsulinemia that was formed in the human population at early stages of development and was fixed genetically in the process of evolution is suggested to underlie pathogenesis of the currently most widely spread diseases of the cardiovascular system (atherosclerosis and hypertension) as well as diabetes mellitus of the 2 type and obesity that are concomitant with a high frequency. Under conditions of civilization, chronic hyperinsulinemia can develop in response to the regularly excessive nutrition. The consequence of the excessive food consumption and the chronic hyperinsulinemia can be overcrowding with lipids (triglycerides) of adipose tissue—the organism lipid store. The natural protective reaction of the cell that contains the limitedly possible amount of lipids is a decrease of the number of insulin receptors and development of insulin resistance. The insulin resistance, in turn, provides the appearance of hyper- and dislipoproteinemia alongside with hyperglycemia. One of the most clinically significant ways of achievement of homeostasis is storage of lipids in the arterial wall. Atherogenic and other concomitant metabolic disorders, specifically changes of blood coagulation properties providing susceptibility to hypercoagulation, affect the blood rheological properties and seem to lead to pathology of the entire vascular system: chronic venous insufficiency, disturbance of microcirculation, and arterial atherosclerosis. There is substantiated the natural interconnection of atherosclerosis, type 2 diabetes, obesity, and arterial hypertension that at present are accepted as the main clinical manifestations of the so-called “metabolic syndrome.” It is suggested that the basis for arterial hypertension might be disturbances of microcirculation leading to an increase of peripheral vascular resistance as well as insufficiency of renal blood supply at the level of arterial and microcirculatory bed.
Similar content being viewed by others
REFERENCES
Anichkov, N.N., On Spread of Atherosclerosis According to Data of the Section Material, Trudy Leningradskogo meditsinskogo vuza bol’nitsy im. Mechnikova (Proceedings of Leningrad Medical School of Mechnikov Hospital), Leningrad, 1935, pp. 17–25.
Vikhert, A.M. and Zhdanov, V.S, Ateroskleroz pri razlichnykh zabolevaniyakh (Atherosclerosis in Various Diseases), Moscow, 1976.
Liberman, I.S., Genetical and Clinical Heterogeneity of Diabetes Mellitus, Doctorate Sci. Dissertation, Moscow, 1988.
Davidenkova, E.F. and Liberman, I.S., Genetika sakharnogo diabeta (Genetics of Diabetes Mellitus), Leningrad, 1988.
Davidenkova, E.F., Liberman, I.S., and Shafran, M.G., Genetical and Pathogenetical Mechanisms of Atherosclerosis, Klin. Medits., 1990, no. 10, pp. 23–31.
Liberman, I.S., Genetical and Pathogenetical Association of Diabetes Mellitus and Vascular Pathology, Ross. Kardiol. Zh., 1997, no. 6, pp. 3–10.
Davidenkova, E.F., Kolosova, N.N., and Liberman, I.S., Mediko-geneticheskoe konsul’tirovanie v sisteme profilaktiki ishemicheskoi bolezni serdtsa i insul’tov (Medical-Genetical Consulting in the System of Prevention of Ischemic Heart Disease and Insults), Leningrad, 1979.
Blagosklonnaya, Ya.V., Almazov, V.A., and Krasil’nikova, E.I., Common Features of Pathogenetical Mechanisms of the Ischemic Heart Disease and Insulin-Independent Diabetes, Prevention, Treatment, Kardiol., 1996, no. 5, pp. 35–39.
Dilman, V.M., Chetyre modeli meditsiny (Four Models of Medicine), Leningrad, 1987.
Stern, M.P., Diabetes and Cardiovascular Disease. The “Common Soil” Hypothesis. Review, Diabetes, 1995, vol. 44, pp. 369–374.
Zimin, Yu.V., Arterial Hypertension in Diabetes: Peculiarities of Pathogenesis and Treatment (Review), Terap. Arkh., 1998, no. 10, pp. 15–20.
Baillie, G.M., Sherer, J.T., and Weart, C.W., Insulin and Coronary Artery Disease: Is Syndrome X the Unifying Hypothesis? Review, Ann. Pharmacother., 1998, vol. 32, pp. 233–247.
Karam, J.H., Type 2 Diabetes and Syndrome X. Pathogenesis and Glycemic Management. Review, Endocrinol. Metab. Clinics North Amer., 1992, vol. 21, pp. 329–350.
Almazov, V.A., Blagosklonnaya, Ya.V., Shlyakhto, E.V., and Krasil’nikova, E.I., Metabolicheskii serdechno-sosudistyi sindrom (Metabolic Cardiovascular Syndrome), St. Petersburg, 1999.
Parfenova, N.S., Metabolic Syndrome, Ross. Kardiol. Zh., 1998, no. 2, pp. 42–48.
Reaven, J.M., Banting Lecture. Role of Insulin Resistance in Human Disease, Diabetes, 1988, vol. 37, pp. 1595–1607.
Daae, L.N., Kierulf, P., Landaas, S., and Urdal, P., Cardiovascular Risk Factors Interactive of Lipids, Coagulation and Fibrinolysis [Review], Scand. J. Clin. Labor. Invest., Suppl., 1993, vol. 215, pp. 19–27.
Jensen, M.D., Diet Effects on Fatty Acid Metabolism in Lean and Obese Humans. Review, Am. J. Clin. Nutrit., 1998, vol. 67,suppl. 3, pp. 531S–534S.
Neel, J.V., Diabetes Mellitus: A “Thrifty” Genotype Rendered Detrimental by “ Progress”?, Am. J. Hum. Genet., 1962, vol. 14, pp. 353–362.
Knowler, W.C., Pettitt, D.J., Bennett, P.H., and Williams, R.C., Diabetes Mellitus in the Pima Indians: Genetic and Evolutionary Considerations, Am. J. Phys. Anthropol., 1983, vol. 62, pp. 107–114.
Zimmet, P., Type 2 (Non Insulin-Dependent) Diabetes—An Epidemiological Overview, Diabetol., 1982, vol. 22, pp. 399–411.
Lipovetskii, B.M. and Shlimovich, P.B., On Interrelation of Lipid and Carbohydrate Metabolisms with Hyperinsulinemia in Atherosclerosis of Coronary Arteries, Kardiol., 1975, no. 7, pp. 101–106.
Stout, R.W., Diabetes and Atherosclerosis. The Role of Insulin, Diabetol., 1979, vol. 16, pp. 141–150.
Yudkin, J., Sucrose, Insulin and Coronary Heart Disease, Am. Heart J., 1970, vol. 80, pp. 844–846.
Standl, E., Hyperinsulinemia and Atherosclerosis. Review. Clinical and Investigative Medicine, Med. Clin. Exper., 1995, vol. 18, pp. 261–266.
Bonner, G., Hyperinsulinemia, Insulin Resistance and Hypertension. Review, J. Cardiovasc. Pharmacol., 1994, vol. 24,suppl. 2, pp. 839–849.
Brunelli, C., Spallarossa, P., Cordera, R., and Caponnetto, S., Hyperinsulinemia and Cardiovascular Risk. Review, Cardiol., 1994, vol. 39,suppl. 1, pp. 163–168.
Barnard, R.J., Faria, D.J., Menges, J.E., and Martin, D.A., Effects of High-Fat, Sucrose Diet on Serum Insulin and Related Atherosclerosis Risk Factors in Rats, Atheroscler., 1993, vol. 100, pp. 229–236.
Kovalev, Yu.R. and Dzeranova, N.F., Test for Glucose Tolerance and Level of Immunoreactive Insuline in Relatives of Patients with Coronary Atherosclerosis, Terap. Arkh., 1984, no. 1, pp. 76–81.
Beyul, E.F., Oleneva, V.A., and Shaternikov, V.A., Ozhirenie (Obesity), Moscow, 1986.
Leites, S.M. and Lapteva, N.N., Ocherki po patofiziologii obmena veshchestv i endokrinnoi sistemy (Essays of Pathophysiology of Metabolism and Endocrine System), Moscow, 1967.
Bjorntorp, P., Obesity, Med. Prisma, 1972, vol. 5, pp. 1–39.
Immunoreactivnost’i ateroskleroz (Immunoreactivity and Atherosclerosis), Klimov, A.N., Ed., Leningrad, 1986.
Klimov, A.N. and Denisenko, A.D., On the Role of Lipoprotein—Antibody Immune Complexes in Atherogenesis, Usp. Sovr. Biol., 1988, vol. 106, Issue2, no. 5, pp. 279–289.
Lipovetskii, B.M., Klinicheskaya lipidologiya (Clinical Lipidology), St. Petersburg, 2000.
Peeifle, B. and Ditschuneit, H., Two Separate Receptors for Insulin and Insulinlike Growth Factors on Arterial Smooth Muscle Cells, Exp. Clin. Endocrinol., 1983, vol. 8, no.3, pp. 280–286.
Okumura, K., Kukuchi, M., Matsui, H., Naruse, K., Shimuzu, K., Toki, Y., Hashimoto, H., and Ito, T., Abnormal Arachidonate Distribution in Low-Density Lipoprotein and Thoracic Aorta in Hyperinsulinemia, Metabol. Clin. Exper., 1995, vol. 44, pp. 806–811.
Stern, M.P., Do Non-Insulin-Dependent Diabetes Mellitus and Cardiovascular Disease Share Common Antecedents? Review, Ann. Intern. Med., 1996, vol. 124, no.1, Part 2, pp. 110–116.
Gundarov, I.A. and Matveeva, S.V., Insufficient Body Mass as a Risk Factor of Death from Cardiovascular Diseases, Terap. Arkh., 2000, no. 1, pp. 72–74.
Liberman, I.S., Ivanov, S.N., Vinogradova, T.V., and Avenirova, E.L., Comparative Study of Peripheral Blood Circulation, Lipid Metabolism, and Hemocoagulation in Families of Patients with Atherosclerosis and Diabetes Mellitus, Terap. Arkh., 1998, no. 10, pp. 10–15.
Matsuoka, T., Kajimoto, Y., Watada, H., Kishimoto, M., Umayahara, Y., Fujitani, Y., Kaneto, H., Kamada, T., Kawamori, R., and Yamasaki, Y., Glutathion-Dependent, Reactive Oxygen Species-Mediated Suppression of the Insulin Gene Promoter Activity in HIT Cells, J. Clin. Invest., 1997, vol. 99, no.1, pp. 144–150.
Weaver, J.U., Koppelman, P.G., and Hitman, G.A., Central Obesity and Hyperinsulinemia in Women are Associated with Polymorphism in the 5’ Flanking Region of the Human Insulin Gene, Eur. J. Clin. Invest., 1992, vol. 22, pp. 265–270.
Yildiz, N., Diedrich, T., and Knepel, W., Nuclear Protein Binding and Functional Activity of a Variant Insulin Gene in Non-Insulin-Dependent Diabetes Mellitus, Exp. Clin. Endocrin. Diab., 1996, vol. 104, pp. 218–227.
Gogin, E.E., Senenko, A.N., and Tyurin, E.I., Arterial’nye gipertenzii (Arterial Hypertensions), Leningrad, 1978.
Evsikov, E.M., Lyusov, V.A., Baikova, O.A., Shapirova, Zh.B., and Kugaenko, N.O., Character of Vascular Lesions and Sensitivity to Hypotensive Therapy in Patients with Arterial Hypertension with Obesity and Basal Hyperinsulinemia, Ross. Kardiol., 2001, no. 1, pp. 13–19.
Liberman, I.S., Metabolic Syndrome in the Light of Evolutionary-Genetical Regularities, Ross. Kardiol., 2002, no. 1, pp. 85–89.
Liberman, I.S., Evolutionary Genetics, Civilization and Metabolic Syndrome, European Atherosclerosis Society, 73rd EAS Congress, Salzburg, Austria, July 7–10, 2002, Abstract Book, p. 305.
Author information
Authors and Affiliations
Additional information
__________
Translated from Zhurnal Evolyutsionnoi Biokhimii i Fiziologii, Vol. 41, No. 2, 2005, pp. 186–191.
Original Russian Text Copyright © 2005 by Liberman.
Rights and permissions
About this article
Cite this article
Liberman, I.S. Evolutional Genetics and Diseases of Civilization. J Evol Biochem Phys 41, 233–239 (2005). https://doi.org/10.1007/s10893-005-0058-7
Received:
Issue Date:
DOI: https://doi.org/10.1007/s10893-005-0058-7